MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis

Hongbing Guan1, Daping Fan, Davit Mrelashvili

  • 1Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.

Insights

MicroRNA let-7e is upregulated in a multiple sclerosis animal model, influencing T-cell differentiation and disease severity. Silencing let-7e reduces disease, suggesting its role in multiple sclerosis pathogenesis.

Area of Science:

  • Immunology
  • Neuroscience
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of immune responses.
  • Evidence suggests miRNAs contribute to multiple sclerosis (MS) pathogenesis, but mechanisms remain unclear.
  • Identifying novel miRNAs in MS pathogenesis could aid early diagnosis and treatment.

Purpose of the Study:

  • To investigate the role of miRNA let-7e in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of MS.
  • To identify specific immune cells and molecular targets regulated by let-7e in EAE.

Main Methods:

  • miRNA array and quantitative real-time PCR to measure let-7e levels in EAE models.
  • Analysis of let-7e expression in specific immune cell populations (CD4+ T cells, CNS mononuclear cells).
  • In vivo silencing and overexpression of let-7e to assess its impact on EAE development and T-cell differentiation.

Main Results:

  • let-7e was significantly upregulated in EAE, correlating with disease development.
  • let-7e expression was primarily observed in CD4+ T cells and CNS-infiltrated mononuclear cells.
  • let-7e silencing attenuated EAE by inhibiting Th1/Th17 cells and increasing Th2 cells.
  • let-7e overexpression enhanced Th1/Th17 cells and aggravated EAE.
  • Interleukin-10 (IL-10) was identified as a functional target of let-7e.

Conclusions:

  • let-7e is a novel miRNA implicated in regulating encephalitogenic T-cell differentiation.
  • let-7e plays a significant role in the pathogenesis of EAE.
  • let-7e may serve as a potential therapeutic target for MS.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...